Stock BOLD BOUNDLESS BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Boundless Bio, Inc.

Equities

BOLD

US10170A1007

Real-time Estimate Cboe BZX
Other stock markets
 01:43:14 2024-06-03 pm EDT 		5-day change 1st Jan Change
8.97 USD -1.64% Intraday chart for Boundless Bio, Inc. -7.50% 0.00%
Apr. 22 Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target MT
Apr. 22 Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
BOUNDLESS BIO, INC.
Bio Therapeutic Drugs
-2.63%-7.50% - - - 203M
Bearish
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. BOLD Stock
  4. Charts Boundless Bio, Inc.
  5. Relative Strength Chart